Cara Therapeutics Inc (CARA)
0.6712
-0.06
(-8.53%)
USD |
NASDAQ |
May 24, 16:00
0.6975
+0.03
(+3.92%)
After-Hours: 20:00
Cara Therapeutics Cash from Investing (Quarterly): 25.95M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 25.95M |
December 31, 2023 | -30.20M |
September 30, 2023 | 23.16M |
June 30, 2023 | 32.80M |
March 31, 2023 | 17.71M |
December 31, 2022 | 44.42M |
September 30, 2022 | 21.18M |
June 30, 2022 | 29.68M |
March 31, 2022 | 33.43M |
December 31, 2021 | -53.58M |
September 30, 2021 | 14.43M |
June 30, 2021 | 20.53M |
March 31, 2021 | 13.87M |
December 31, 2020 | -164.16M |
September 30, 2020 | 39.54M |
June 30, 2020 | 67.38M |
March 31, 2020 | 36.96M |
December 31, 2019 | 14.74M |
September 30, 2019 | -96.88M |
June 30, 2019 | 25.23M |
March 31, 2019 | 26.40M |
December 31, 2018 | -57.83M |
Date | Value |
---|---|
September 30, 2018 | 5.454M |
June 30, 2018 | -51.14M |
March 31, 2018 | 20.69M |
December 31, 2017 | 8.126M |
September 30, 2017 | 12.08M |
June 30, 2017 | -71.40M |
March 31, 2017 | 14.70M |
December 31, 2016 | 20.54M |
September 30, 2016 | 14.78M |
June 30, 2016 | 7.082M |
March 31, 2016 | 2.614M |
December 31, 2015 | -91.66M |
September 30, 2015 | -0.001M |
June 30, 2015 | -0.006M |
March 31, 2015 | -0.006M |
December 31, 2014 | -0.015M |
September 30, 2014 | -0.021M |
June 30, 2014 | -0.006M |
March 31, 2014 | 0.00 |
December 31, 2013 | -0.001M |
September 30, 2013 | -0.004M |
June 30, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-164.16M
Minimum
Dec 2020
67.38M
Maximum
Jun 2020
5.809M
Average
22.17M
Median
Cash from Investing (Quarterly) Benchmarks
Stereotaxis Inc | 0.00 |
Nektar Therapeutics | 19.26M |
Avid Bioservices Inc | -4.488M |
Rigel Pharmaceuticals Inc | 0.313M |
Voyager Therapeutics Inc | -96.06M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -30.45M |
Cash from Financing (Quarterly) | -0.685M |
Free Cash Flow | -91.12M |
Free Cash Flow Per Share (Quarterly) | -0.5732 |
Free Cash Flow to Equity (Quarterly) | -31.29M |
Free Cash Flow Yield | -249.9% |